Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M. Swango"'
Publikováno v:
Journal of Clinical Oncology. 25:19640-19640
19640 Background: Neurotoxicity caused by taxane chemotherapies(CT) can be dose limiting and can cause a decrease in quality of life. Melatonin has been evaluated for its use in decreasing adverse reactions of CT. Preclinical data suggests that melat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::427521e621a426b5b06a5123a9a17470
https://doi.org/10.1200/jco.2007.25.18_suppl.19640
https://doi.org/10.1200/jco.2007.25.18_suppl.19640
